Provided by Tiger Fintech (Singapore) Pte. Ltd.

Black Diamond Therapeutics, Inc.

2.81
+0.00920.33%
Volume:196.49K
Turnover:559.78K
Market Cap:159.94M
PE:11.22
High:2.95
Open:2.82
Low:2.79
Close:2.80
52wk High:6.33
52wk Low:1.20
Shares:56.94M
Float Shares:39.24M
Volume Ratio:1.39
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2503
EPS(LYR):-1.2662
ROE:11.85%
ROA:3.02%
PB:1.21
PE(LYR):-2.22

Loading ...

3 Penny Stocks to Watch Now, 3/20/25

TIPRANKS
·
Mar 20

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires Live
·
Mar 20

Top Midday Gainers

MT Newswires
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Aterian, Autodesk, Ollie's

Reuters
·
Mar 19

BUZZ-Black Diamond rises on licensing deal for tumor treatment

Reuters
·
Mar 19

Black Diamond, Servier announce global licensing agreement for BDTX-4933

TIPRANKS
·
Mar 19

BRIEF-Servier And Black Diamond Therapeutics Announce Global Licensing Agreement For BDTX-4933, A Targeted Oncology Therapy

Reuters
·
Mar 19

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

GlobeNewswire
·
Mar 19

Black Diamond Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 10

Black Diamond Therapeutics Reports 2024 Financial Results

TIPRANKS
·
Mar 08

Black Diamond Therapeutics price target lowered to $15 from $16 at Stifel

TIPRANKS
·
Mar 07

Black Diamond Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
Mar 07

Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating

MT Newswires Live
·
Mar 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 07

Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)

TIPRANKS
·
Mar 07

Black Diamond: Q4 Earnings Snapshot

Associated Press Finance
·
Mar 07

Black Diamond Therapeutic Q4 EPS $(0.28) Beats $(0.31) Estimate

Benzinga
·
Mar 07

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
Mar 07